Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), bought 2,180 shares at $24.80 ($54K) on 2019-09-26, disclosed to the SEC on 2019-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AXSM | SELL | 2025-02-14 | $3.5M | — | Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |